Total Payments
$995.90
2024 Payments
$242.78
Companies
16
Transactions
48
Medicare Patients
1,446
Medicare Billing
$235,019
Payment Breakdown by Category
Food & Beverage$995.90 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $995.90 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $304.80 | 16 | $0 (2024) |
| ABBVIE INC. | $269.02 | 12 | $0 (2024) |
| Amgen Inc. | $68.39 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $53.07 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $45.50 | 2 | $0 (2023) |
| PFIZER INC. | $41.15 | 2 | $0 (2021) |
| Gilead Sciences, Inc. | $33.17 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $27.66 | 1 | $0 (2023) |
| Eisai Inc. | $26.67 | 2 | $0 (2021) |
| Xeris Pharmaceuticals, Inc. | $24.61 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.78 | 11 | AstraZeneca Pharmaceuticals LP ($98.07) |
| 2023 | $335.02 | 15 | AstraZeneca Pharmaceuticals LP ($147.24) |
| 2022 | $193.17 | 10 | ABBVIE INC. ($73.13) |
| 2021 | $224.93 | 12 | AbbVie Inc. ($126.36) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/24/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Bone Health | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Bone Health | ||||||
| 05/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Neurology | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Respiratory | ||||||
| 03/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Respiratory | ||||||
| 10/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Respiratory | ||||||
| 08/28/2023 | Merck Sharp & Dohme LLC | JANUVIA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/22/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.17 | General |
| 08/03/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Bone Health | ||||||
| 06/30/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Respiratory | ||||||
| 04/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Respiratory | ||||||
| 03/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 412 | 776 | $210,519 | $65,460 |
| 2022 | 12 | 393 | 740 | $180,701 | $61,368 |
| 2021 | 11 | 333 | 781 | $163,327 | $58,940 |
| 2020 | 11 | 308 | 758 | $161,462 | $49,252 |
Total Patients
1,446
Total Services
3,055
Medicare Billing
$235,019
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 471 | $141,375 | $43,299 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 116 | $46,400 | $16,806 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $5,355 | $2,367 | 44.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 14 | $4,172 | $725.36 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,200 | $540.33 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,540 | $380.14 | 10.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 30 | $1,950 | $308.35 | 15.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 31 | $930.00 | $295.12 | 31.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $2,046 | $287.88 | 14.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 26 | $910.00 | $218.40 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 19 | $1,425 | $192.00 | 13.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 18 | $216.00 | $39.60 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 418 | $120,857 | $38,591 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 102 | $34,884 | $15,098 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $5,700 | $2,728 | 47.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,888 | $1,655 | 28.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 31 | $3,215 | $1,013 | 31.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 21 | 21 | $3,726 | $892.35 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $2,076 | $563.08 | 27.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 22 | 32 | $896.00 | $306.69 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 22 | $1,320 | $208.95 | 15.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 18 | $1,278 | $207.06 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 21 | $630.00 | $59.28 | 9.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 21 | $231.00 | $44.36 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 350 | $101,150 | $34,589 | 34.2% |
About Robert Mcrorie
Robert Mcrorie is a Physician Assistant healthcare provider based in Kenai, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1972906899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Mcrorie has received a total of $995.90 in payments from pharmaceutical and medical device companies, with $242.78 received in 2024. These payments were reported across 48 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($995.90).
As a Medicare-enrolled provider, Mcrorie has provided services to 1,446 Medicare beneficiaries, totaling 3,055 services with total Medicare billing of $235,019. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Kenai, AK
- Active Since 10/06/2014
- Last Updated 12/29/2014
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972906899
Products in Payments
- BREZTRI (Drug) $201.61
- UBRELVY (Drug) $196.96
- FARXIGA (Drug) $70.61
- EVENITY (Biological) $68.39
- VRAYLAR (Drug) $54.00
- ENTRESTO (Drug) $45.50
- ELIQUIS (Drug) $41.15
- AIRSUPRA (Drug) $32.58
- UZEDY (Drug) $29.35
- JANUVIA (Drug) $27.66
- Dayvigo (Drug) $26.67
- GVOKE HYPOPEN (Drug) $24.61
- AUSTEDO (Drug) $23.72
- NURTEC ODT (Drug) $22.05
- QULIPTA (Drug) $18.06
- XYOSTED (Drug) $17.28
- Rybelsus (Drug) $17.00
- Vascepa (Drug) $16.91
- NUCALA (Biological) $16.07
- CAPLYTA (Drug) $12.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Kenai
Mr. Jared Wallace, Pa-C, PA-C
Physician Assistant — Payments: $4,147
Physician Assistant $4,147
Mark Restad, Pa-C, PA-C
Physician Assistant — Payments: $1,519
Physician Assistant $1,519
Ms. Rene' Kenney, Rn, Pa-C, RN, PA-C
Physician Assistant
Physician Assistant
Mr. Mark Mencel, Pa-C, PA-C
Physician Assistant
Physician Assistant
Sarah Kurka, Pa-C, PA-C
Physician Assistant
Physician Assistant